HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A microbiological study of failed penicillin therapy for gonococcal urethritis in Durban.

Abstract
Seventy-five men presenting with persistent urethral discharge after penicillin therapy were investigated for sexually transmitted pathogens during July - September 1987. The major aetiological agent isolated was Neisseria gonorrhoeae (58 patients (77.3%]. Penicillinase-producing N. gonorrhoeae (PPNG) accounted for 58.6% of 58 isolates. Chlamydia trachomatis was detected in 10.7% of patients and Trichomonas vaginalis in 14.7% of patients. When there is a high prevalence of PPNG, the use of penicillin as a first-line agent for therapy should be discontinued in favour of an agent active against PPNG and non-PPNG strains. Furthermore, in view of the relatively high prevalence of T. vaginalis, patients returning with persistent urethral discharge should be investigated and treated for infection with this protozoan.
AuthorsA A Hoosen, K D Coetzee, J van den Ende
JournalSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde (S Afr Med J) Vol. 78 Issue 4 Pg. 189-91 (Aug 18 1990) ISSN: 0256-9574 [Print] South Africa
PMID2116671 (Publication Type: Journal Article)
Chemical References
  • Penicillin G Procaine
  • Penicillin G
Topics
  • Adolescent
  • Adult
  • Animals
  • Chlamydia trachomatis (isolation & purification)
  • Drug Resistance, Microbial
  • Gonorrhea (drug therapy, microbiology)
  • Humans
  • Male
  • Middle Aged
  • Neisseria gonorrhoeae (isolation & purification)
  • Penicillin G (therapeutic use)
  • Penicillin G Procaine (therapeutic use)
  • Recurrence
  • Trichomonas vaginalis (isolation & purification)
  • Urethritis (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: